Immunomodulators Market

Immunomodulators Market Size by Type (Immunosuppressants, Immunostimulants), Route of Administration (Oral, Injectable, Intravenous), Application, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12509
  • Published Date: Oct, 2021
  • Pages: 217
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Global immunomodulators market is projected to reach USD 255.67 billion by 2028, at a CAGR of 5.15% from 2021 to 2028. Global immunomodulators market is witnessing a considerable growth owing to increasing incidences of autoimmune diseases across the globe.          

Market Overview:

Immunomodulators are the agents that stimulate the response of immune system by modulating immune response. They help normalize or regulate the immune system by either stimulating or suppressing the immune system. Immunostimulants, such as interferons and vaccines, enhance the body's resistance against infections. Immunomodulators generally classified into two categories: immunostimulants and immunosuppressants. There are several types of medications and therapy are available in each category, with unique mechanisms of action, indications (both labelled and unlabeled), and with novel immune targets. The number of drugs that are used to treat autoimmune disorders have raised in past few years. The immunomodulators have helped a lot in the treatments and thus resulting in slow disease progression. Each type of immunomodulator medication contains a particular kind of active ingredient which works by altering the way of immune system carries out its functions in a specific person's body. These drugs work by weakening or suppressing the immune system or by modifying the way it works in different ways. Immunosuppressant drugs are used to reduce the immune response by modifying the function or production of cytokines and immune cells.

Immunomodulators are widely used in chronic illness and recommended for people with autoimmune diseases, as they help to restore immune system health in people who have been on lengthy courses of antibiotics or anti-viral therapies. There are ongoing trends of immunomodulation to combat a vast range of animal and human diseases, including incurable diseases like cancers, autoimmune diseases, viral diseases, and inflammatory conditions. Immunomodulators drugs are most commonly used to treat autoimmune disorders that are severe or moderate. The majority of new immunomodulators are in development, which is likely to provide more growth opportunities in the market. Major players such as GSK and Pfizer are focusing on the development of new drugs.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:
  • Rising incidences of multiple sclerosis propelling the market growth

In multiple sclerosis (MS), the immune system attacks nerve cells, causing symptoms that can include weakness, poor coordination, muscle spasms, pain, and blindness. It is one of the most common disorder and poses a significant personal and socioeconomic burden. For instance, as per the study by National Society of MS, currently, an estimated 2.3 million people live with multiple sclerosis worldwide. Immunomodulators are used for the treatment of various forms of multiple sclerosis. Thus, rising incidences of multiple sclerosis are propelling the market growth.

  • Increasing adoption of immunomodulator therapy for the treatment of Crohn's disease

Immunomodulator is an effective treatment for people with Crohn's disease. It can be used either single in pair with other medications. These drugs help to modify or weaken the immune system to reduce inflammation caused by Crohn's disease, which can help to reduce symptoms and keep the patients in remission. Thus, increasing adoption of immunomodulator therapy for the treatment of Crohn's disease, driving the growth of the market. 

Restraints:
  • Adverse side effects of immunomodulator drugs

There is a greater risk of infection, including both primary infection and reactivation of latent infections. These infections include hepatitis B and hepatitis C viruses, tuberculosis (TB), fungal infections, and HIV. There is also a high risk of progressive multifocal leukoencephalopathy (PML). Thus, before the initiation of immunomodulator treatment, patients must be screened for these threats or historical exposure to the viruses associated with these diseases.

Opportunities:
  • Increasing R&D activities will provide future growth opportunities

The increasing interest in immunomodulators leads to the discovery and development of a diverse array of new drugs and treatment for the various autoimmune disorders. Many key vendors are investing heavily in the research and development activities and focusing on the launching the new drugs cater to the demand of a large number of customers. A number of disorders such as autoimmune disease, immunodeficiency state, cancer and viral infection can be treated with immunostimulants drugs. Thus, with the widening scope of immunomodulators to manage a large number of diseases, offering potential opportunities for the major vendors in the market.

Challenges:
  • Stringent government regulations for the approval and launch of the drug

Stringent government regulations for the approval and launch of the immunomodulators drug is one of the critical challenges for the vendors.  For the approval of the drugs, drug manufacturers must conduct lab, animal, and human clinical testing and submit their data to the respective regulatory institutes to verify the safety and efficacy of the drug. The approval of the drug procedure consumes a lot of time and requires substantial capital investment. Thus, these factors are anticipated to hinder the market growth over the forecast period.

Segmentation Analysis:

The global immunomodulators market has been segmented based on type, route of administration, application, and regions.

  • The type segment is divided into immunosuppressants and immunostimulants. The immunosuppressants segment further classified into calcineurin inhibitors, antimetabolites, glucocorticoids, and others. Immunostimulants further divided into vaccines, antibodies, others. Immunosuppressants segment led the immunomodulators market with the highest market share and valued at USD 91.08 billion in 2020. This is mainly attributed to the presence of an extensive product range in this segment with the ability to treat the variety of autoimmune diseases. These drugs suppress or reduce, the strength of the body's immune system. These drugs are given for autoimmune disorders such as multiple sclerosis (MS), Rheumatoid arthritis, alopecia areata, and lupus, to decrease the undesirable immune response of the body.
  • The route of administration segment includes oral, injectable, and intravenous. The oral route of administration is estimated to grow at the highest CAGR of 5.9% over the forecast period, as it is one of the most convenient and usually the safest and least expensive route of administration. After oral administration, these drugs quickly absorbed and approximately 30% circulates in the blood bound to plasma proteins. Drugs, in the form of liquids, capsules, tablets, or chewable tablets, can be taken orally.
  • The application segment includes respiratory, human immunodeficiency virus (HIV), oncology, and others. Other segment includes disease such as multiple sclerosis, Crohn's disease, rheumatoid arthritis, etc. Other segment accounted for the major market share of 45.6% in 2020. This is mainly due to the widely used of immunomodulators for the treatment of these diseases. These drugs have been used for over two decades to treat relapsing these diseases. Immunomodulators help to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations.
Regional Segmentation Analysis:

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. The North America region emerged as the largest market for the immunomodulators market, with a 38.7% share of the market revenue in 2020.

  • This is because North America has the highest number of populations suffering from autoimmune diseases. In addition to this, the presence of a large number of companies in the region, positively impacting the growth of the market. For instance, as per the study of the National Institute of Environmental Science, autoimmune diseases affect over than 24 million people in the United States. In addition to this, as per the National Multiple Sclerosis Society, Canada is the country, which has the highest prevalence of multiple sclerosis in the world. Thus, the rising incidence of these diseases in the countries such as U.S. and Canada, driving the growth of the market.
  • The Asia Pacific region is anticipated to hold the considerable market share in the global immunomodulators market, owing to rising awareness about various immune disorders, In addition to this, favourable government regulations and increasing healthcare expenditure in the countries such as India and China, further propelling the growth of the market in the Asia Pacific region. 

North America Immunomodulators Market Share in 2020- 38.7%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global immunomodulators industry.

In October 2019, Pandion Therapeutics, Inc. and Astellas Pharma Inc. announced the partnership for the development and market launch of immunomodulator drugs for pancreas autoimmune disease.

In January 2020, KYORIN Holdings, Inc. announced that their subsidiary KYORIN Pharmaceutical Co., Ltd has entered into a partnership and license agreement with aTyrPharma, Inc. for Japan with regard to ATYR1923, aTyr's novel immunomodulator to develop and commercialize ATYR1923 for interstitial lung diseases in Japan.

List of Key Market Players:

  • Hoffmann-La Roche Ltd.
  • Amgen Inc.
  • Abbott Laboratories
  • Johnson & Johnson
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Merck & Co.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Biogen Inc.
  • Teva Pharmaceuticals
  • Pandion Therapeutics, Inc.
  • aTyrPharma, Inc.

Key Target Audience

  • Healthcare Institutes
  • Drug Manufacturers
  • Pharmaceutical Companies
  • Government Authorities and R&D Institutions
  • World Health Organization
  • Food and Drug Administration
  • Consulting And Research Firms

Report Description:

  • Global Immunomodulators Market, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2028 are the forecast years. The global immunomodulators market is based on revenue (USD Million/Billion). The report incorporates the market study on the basis of revenue. The study covers the market share revenue/market share for each of the segments, regions and countries catering to global immunomodulators market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of immunomodulators and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global immunomodulators market. This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global immunomodulators market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global immunomodulators market is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the immunomodulators market was valued at USD 171.05 billion in 2020 and is anticipated to reach USD 255.67 billion by 2028.

Global immunomodulators market is growing at a CAGR of 5.15% during the forecast period 2021-2028.

The global immunomodulators market has been segmented based on type, route of administration, application, and regions. Immunosuppressants segment led the immunomodulators market with the highest market share in 2020.

The North America region emerged as the largest market for the immunomodulators.

Rising incidences of multiple sclerosis is the key driving factor for the immunomodulators market

Adverse side effects of immunomodulator drugs may hamper the market growth.

Increasing R&D activities will provide huge opportunities to the market.

Key players are Hoffmann-La Roche Ltd., Amgen Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Type
          4.3.2. Market Attractiveness Analysis By Route of Administration
          4.3.3. Market Attractiveness Analysis By Application
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising incidences of multiple sclerosis
          5.2.2. Increasing adoption of immunomodulator therapy for the treatment of Crohn's disease
    5.3. Restrains
          5.3.1. Adverse side effects of immunomodulator drugs
    5.4. Opportunities
          5.4.1. Increasing R&D activities
    5.5. Challenges
          5.5.1. Stringent government regulations for the approval and launch of the drug

6. Global Immunomodulators Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Immunosuppressants
          6.2.1. Calcineurin Inhibitors
          6.2.2. Antibodies
          6.2.3. Antimetabolites
          6.2.4. Glucocorticoids
          6.2.5. Others
    6.3. Immunostimulants
          6.3.1. Vaccines
          6.3.2. Antibodies
          6.3.3. Others

7. Global Immunomodulators Market Analysis and Forecast, By Route of Administration
    7.1. Segment Overview
    7.2. Oral
    7.3. Injectable
    7.4. Intravenous

8. Global Immunomodulators Market Analysis and Forecast, By Application
    8.1. Segment Overview
    8.2. Respiratory
    8.3. Human Immunodeficiency Virus (HIV)
    8.4. Oncology
    8.5. Others

9. Global Immunomodulators Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Immunomodulators Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in Global Immunomodulators Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Hoffmann-La Roche Ltd.
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Amgen Inc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Abbott Laboratories
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Johnson & Johnson
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Novartis AG
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Bristol-Myers Squibb Company
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Merck & Co.
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Eli Lilly and Company
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Pfizer Inc.
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Biogen Inc.
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Teva Pharmaceuticals
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. Pandion Therapeutics, Inc.
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. aTyr Pharma, Inc.
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
 

List of Table

1. Global Immunomodulators Market, By Type, 2018–2028(USD Billion)

2. Global Immunosuppressants Immunomodulators Market, By Region, 2018–2028(USD Billion)

3. Global Immunostimulants Immunomodulators Market, By Region, 2018–2028(USD Billion)

4. Global Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

5. Global Oral Immunomodulators Market, By Region, 2018–2028(USD Billion)

6. Global Injectable Immunomodulators Market, By Region, 2018–2028(USD Billion)

7. Global Intravenous Immunomodulators Market, By Region, 2018–2028(USD Billion)

8. Global Immunomodulators Market, By Application, 2018–2028(USD Billion)

9. Global Respiratory Immunomodulators Market, By Region, 2018–2028(USD Billion)

10. Global Human Immunodeficiency Virus (HIV)Immunomodulators Market, By Region, 2018–2028(USD Billion)

11. Global Oncology Immunomodulators Market, By Region, 2018–2028 (USD Billion)

12. Global Others Immunomodulators Market, By Region, 2018–2028(USD Billion)

13. Global Immunomodulators Market, By Region, 2018–2028(USD Billion)

14. Global Immunomodulators Market, By North America, 2018–2028(USD Billion)

15. North America Immunomodulators Market, By Type, 2018–2028(USD Billion)

16. North America Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

17. North America Immunomodulators Market, By Application, 2018–2028(USD Billion)

18. U.S. Immunomodulators Market, By Type, 2018–2028(USD Billion)

19. U.S. Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

20. U.S. Immunomodulators Market, By Application, 2018–2028(USD Billion)

21. Canada Immunomodulators Market, By Type, 2018–2028(USD Billion)

22. Canada Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

23. Canada Immunomodulators Market, By Application, 2018–2028(USD Billion)

24. Mexico Immunomodulators Market, By Type, 2018–2028(USD Billion)

25. Mexico Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

26. Mexico Immunomodulators Market, By Application, 2018–2028(USD Billion)

27. Europe Immunomodulators Market, By Type, 2018–2028(USD Billion)

28. Europe Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

29. Europe Immunomodulators Market, By Application, 2018–2028(USD Billion)

30. Germany Immunomodulators Market, By Type, 2018–2028(USD Billion)

31. Germany Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

32. Germany Immunomodulators Market, By Application, 2018–2028(USD Billion)

33. France Immunomodulators Market, By Type, 2018–2028(USD Billion)

34. France Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

35. France Immunomodulators Market, By Application, 2018–2028(USD Billion)

36. U.K. Immunomodulators Market, By Type, 2018–2028(USD Billion)

37. U.K. Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

38. U.K. Immunomodulators Market, By Application, 2018–2028(USD Billion)

39. Italy Immunomodulators Market, By Type, 2018–2028(USD Billion)

40. Italy Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

41. Italy Immunomodulators Market, By Application, 2018–2028(USD Billion)

42. Spain Immunomodulators Market, By Type, 2018–2028(USD Billion)

43. Spain Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

44. Spain Immunomodulators Market, By Application, 2018–2028(USD Billion)

45. Asia Pacific Immunomodulators Market, By Type, 2018–2028(USD Billion)

46. Asia Pacific Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

47. Asia Pacific Immunomodulators Market, By Application, 2018–2028(USD Billion)

48. Japan Immunomodulators Market, By Type, 2018–2028(USD Billion)

49. Japan Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

50. Japan Immunomodulators Market, By Application, 2018–2028(USD Billion)

51. China Immunomodulators Market, By Type, 2018–2028(USD Billion)

52. China Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

53. China Immunomodulators Market, By Application, 2018–2028(USD Billion)

54. India Immunomodulators Market, By Type, 2018–2028(USD Billion)

55. India Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

56. India Immunomodulators Market, By Application, 2018–2028(USD Billion)

57. South America Immunomodulators Market, By Type, 2018–2028(USD Billion)

58. South America Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

59. South America Immunomodulators Market, By Application, 2018–2028(USD Billion)

60. Brazil Immunomodulators Market, By Type, 2018–2028(USD Billion)

61. Brazil Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

62. Brazil Immunomodulators Market, By Application, 2018–2028(USD Billion)

63. Middle East and Africa Immunomodulators Market, By Type, 2018–2028(USD Billion)

64. Middle East and Africa Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

65. Middle East and Africa Immunomodulators Market, By Application, 2018–2028(USD Billion)

66. UAE Immunomodulators Market, By Type, 2018–2028(USD Billion)

67. UAE Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

68. UAE Immunomodulators Market, By Application, 2018–2028(USD Billion)

69. South Africa Immunomodulators Market, By Type, 2018–2028(USD Billion)

70. South Africa Immunomodulators Market, By Route of Administration, 2018–2028(USD Billion)

71. South Africa Immunomodulators Market, By Application, 2018–2028(USD Billion)

List of Figures 

1. Global Immunomodulators Market Segmentation

2. Immunomodulators Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Immunomodulators Market Attractiveness Analysis By Type

9. Global Immunomodulators Market Attractiveness Analysis By Route of Administration

10. Global Immunomodulators Market Attractiveness Analysis By Application

11. Global Immunomodulators Market Attractiveness Analysis By Region

12. Global Immunomodulators Market: Dynamics

13. Global Immunomodulators Market Share By Type (2021 & 2028)

14. Global Immunomodulators Market Share By Route of Administration (2021 & 2028)

15. Global Immunomodulators Market Share By Application(2021 & 2028)

16. Global Immunomodulators Market Share by Regions (2021 & 2028)

17. Global Immunomodulators Market Share by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global immunomodulators market on the basis of below mentioned segments:

Global Immunomodulators Market by Type:

  • Immunosuppressants
    • Calcineurin Inhibitors
    • Antibodies
    • Antimetabolites
    • Glucocorticoids
    • Others
  • Immunostimulants
    • Vaccines
    • Antibodies
    • Others

Global Immunomodulators Market by Route of Administration:

  • Oral
  • Injectable
  • Intravenous

Global Immunomodulators Market by Application:

  • Respiratory
  • Human Immunodeficiency Virus (HIV)
  • Oncology
  • Others

Global Immunomodulators Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa         
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date